Krk Medical Research is categorized under Health Services in Dallas, TX .
Krk Medical Research was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 5619901 by the NAICS.
If you are seeking more information, feel free to contact Robert Freedenfeld, Executive Director at the company’s single location by writing to 6750 Hillcrest Plaza Drive # 215, Dallas, Texas TX 75230 or by phoning (972) 907-1333. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Krk Medical Research |
| Contact Person: | Robert Freedenfeld, Executive Director |
| Address: | 6750 Hillcrest Plaza Drive # 215, Dallas, Texas 75230 |
| Phone Number: | (972) 907-1333 |
| Website Address: | krkmedicalresearch.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 5619901 |
| Share This Business: |
Krk Medical Research was started in 0 to provide professional Health Services under the SIC code 8099 and NAICS code 5619901. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert Freedenfeld, Executive Director for inquiries that concern Krk Medical Research by calling the company number (972) 907-1333, as your correspondence is most welcome. Additionally, the physical location of the single location of Krk Medical Research can be found at the coordinates 32.924087,-96.790662 as well as the street address 6750 Hillcrest Plaza Drive # 215 in Dallas, Texas 75230.
For its online presence, you may visit Krk Medical Research’s website at krkmedicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.